Paracetamol Safe in Pregnancy Study
Analysis based on 7 articles · First reported Jul 01, 2026 · Last updated Jul 06, 2026
The study's findings provide significant reassurance regarding the safety of Paracetamol use during pregnancy, which could lead to increased confidence among expectant mothers and clinicians. This may positively impact the pharmaceutical industry, particularly companies producing Paracetamol, as previous concerns had created uncertainty. The reaffirmation of Paracetamol's safety could also reduce the use of less safe alternatives like Nonsteroidal Anti-inflammatory Drug, benefiting public health.
A comprehensive study led by the University of Hong Kong (HKUMed) and co-led by Aston University has conclusively found that using Paracetamol (acetaminophen) during pregnancy does not increase a child's risk of developing Autism (ASD) or Attention deficit hyperactivity disorder (ADHD). The research, which analyzed electronic medical records of 708,020 mother-child pairs in China — Hong Kong over two decades, utilized a rigorous sibling-matched design to account for genetic and environmental factors. This methodology allowed researchers to overcome limitations of previous observational studies that suggested a link between prenatal Paracetamol exposure and neurodevelopmental disorders. The findings, published in JAMA Internal Medicine, provide timely reassurance for expectant mothers and clinicians globally, supporting the existing safety profiles reaffirmed by organizations like the World Health Organization. Key researchers, including Dr. Shan Luo and Professor Ian Chi-Kei Wong, highlighted the importance of this robust evidence in addressing public and scientific debate that arose partly from statements by the United States administration.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard